Literature DB >> 32691832

Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.

Kady Phe1, Emily L Heil2, Vincent H Tam3.   

Abstract

Critically ill patients with sepsis or septic shock are at an increased risk of death. Early and aggressive interventions are essential for improving clinical outcomes. There are a number of therapeutic and practical challenges in the management of antimicrobials in patients with sepsis. These include the timely selection and administration of appropriate antimicrobials, significant physiological alterations that can influence antimicrobial pharmacokinetics, and significant interpatient variability of antimicrobial concentrations using standard dosing approaches. Understanding the impact of these factors on the probability of attaining pharmacokinetic-pharmacodynamic target goals is essential to guide optimal therapy. Using rapid diagnostic technology could facilitate timely selection of antimicrobials, and therapeutic drug monitoring would provide a more individualized dosing approach. Using an interdisciplinary sepsis team would also be beneficial in coordinating efforts to overcome the challenges encountered during this critical period to ensure optimal care.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibiotics; dosing; monitoring; pharmacokinetics; physiological alterations; treatment

Mesh:

Substances:

Year:  2020        PMID: 32691832      PMCID: PMC7372216          DOI: 10.1093/infdis/jiaa118

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  60 in total

1.  Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.

Authors:  Thomas P Lodise; Ben Lomaestro; George L Drusano
Journal:  Clin Infect Dis       Date:  2007-01-02       Impact factor: 9.079

2.  KDIGO clinical practice guidelines for acute kidney injury.

Authors:  Arif Khwaja
Journal:  Nephron Clin Pract       Date:  2012-08-07

3.  Antimicrobial dosing in critical care: A pragmatic adult dosing nomogram.

Authors:  Paul Williams; Gareth Beall; Menino Osbert Cotta; Jason A Roberts
Journal:  Int J Antimicrob Agents       Date:  2019-11-10       Impact factor: 5.283

Review 4.  Introduction to drug pharmacokinetics in the critically ill patient.

Authors:  Brian S Smith; Dinesh Yogaratnam; Kimberly E Levasseur-Franklin; Allison Forni; Jeffrey Fong
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

Review 5.  Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.

Authors:  Nesrine A Rizk; Zeina A Kanafani; Hussam Z Tabaja; Souha S Kanj
Journal:  Expert Rev Anti Infect Ther       Date:  2017-07-03       Impact factor: 5.091

6.  Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.

Authors:  Leonardo Lorente; Lisset Lorenzo; María M Martín; Alejandro Jiménez; María L Mora
Journal:  Ann Pharmacother       Date:  2006-01-31       Impact factor: 3.154

7.  Impact of a Combination Antibiotic Bag on Compliance With Surviving Sepsis Campaign Goals in Emergency Department Patients With Severe Sepsis and Septic Shock.

Authors:  Michael P Lorenzo; Lindsay MacConaghy; Christopher D Miller; Gregory Meola; Luke A Probst; Brian Pratt; Jeff Steele; Robert W Seabury
Journal:  Ann Pharmacother       Date:  2017-10-27       Impact factor: 3.154

8.  Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.

Authors:  Konstantinos Z Vardakas; Georgios L Voulgaris; Athanasios Maliaros; George Samonis; Matthew E Falagas
Journal:  Lancet Infect Dis       Date:  2017-11-05       Impact factor: 25.071

Review 9.  Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Authors:  Jason A Roberts; Mohd H Abdul-Aziz; Jeffrey Lipman; Johan W Mouton; Alexander A Vinks; Timothy W Felton; William W Hope; Andras Farkas; Michael N Neely; Jerome J Schentag; George Drusano; Otto R Frey; Ursula Theuretzbacher; Joseph L Kuti
Journal:  Lancet Infect Dis       Date:  2014-04-24       Impact factor: 25.071

10.  Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Authors:  Preeti Pancholi; Karen C Carroll; Donna M Wolk; Blake W Buchan; Raymond C Chan; Neelam Dhiman; Bradley Ford; Paul A Granato; Amanda T Harrington; Diana R Hernandez; Romney M Humphries; Matthew R Jindra; Nathan A Ledeboer; Shelley A Miller; A Brian Mochon; Margie A Morgan; Robin Patel; Paul C Schreckenberger; Paul D Stamper; Patricia J Simner; Nancy E Tucci; Cynthia Zimmerman
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

View more
  5 in total

Review 1.  New β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Dafna Yahav; Christian G Giske; Alise Grāmatniece; Henrietta Abodakpi; Vincent H Tam; Leonard Leibovici
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 2.  Antimicrobial Therapy in Pediatric Sepsis: What Is the Best Strategy?

Authors:  Luciana Becker Mau; Vera Bain
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

Review 3.  Beta-Lactams Therapeutic Monitoring in Septic Children-What Target Are We Aiming for? A Scoping Review.

Authors:  Ronaldo Morales Junior; Gabriela Otofuji Pereira; Gustavo Magno Baldin Tiguman; Vanessa D'Amaro Juodinis; João Paulo Telles; Daniela Carla de Souza; Silvia Regina Cavani Jorge Santos
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

Review 4.  The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.

Authors:  Alicia Rodríguez-Gascón; María Ángeles Solinís; Arantxa Isla
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

Review 5.  Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.

Authors:  Pedro Póvoa; Patrícia Moniz; João Gonçalves Pereira; Luís Coelho
Journal:  Microorganisms       Date:  2021-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.